SHRX · Sharp Therapeutics Corp. · Financials
Market Cap
41.20M CAD
Shares
30.08M
Volume · Sep 21
200
Avg daily vol (3 sessions)
1433
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Net Income
-$6.17M
-89.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 |
|---|---|---|
| -$5.51M | -$2.54M | |
| -$6.17M | -$3.26M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.